Literature DB >> 1924318

Ligand-binding and heterodimerization activities of a conserved region in the ligand-binding domain of the thyroid hormone receptor.

R A Spanjaard1, D S Darling, W W Chin.   

Abstract

The ligand-binding domain of the thyroid hormone (3,5,3'-triiodothyronine) receptor (TR) contains poorly characterized subdomains involved with ligand binding, transactivation, and protein-protein interactions. The region between residues 288-331 of rat TR alpha-1 was analyzed by modeling and site-directed mutagenesis. Our results suggest that part of this sequence adopts an amphipathic alpha-helical conformation. The integrity of the putative helix is important for 3,5,3'-triiodothyronine binding but not necessarily for heterodimerization with nuclear factor(s). Mutants defective for both activities were found clustered in a region overlapping the C-terminal portion of the helix and further downstream. The sequence conservation of this particular region among the entire superfamily suggests a similar role in dimerization in other receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924318      PMCID: PMC52554          DOI: 10.1073/pnas.88.19.8587

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

2.  Isolation and characterization of rat cDNA clones for two distinct thyroid hormone receptors.

Authors:  M B Murray; N D Zilz; N L McCreary; M J MacDonald; H C Towle
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

3.  Amino acid preferences for specific locations at the ends of alpha helices.

Authors:  J S Richardson; D C Richardson
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

4.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

Authors:  W H Landschulz; P F Johnson; S L McKnight
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

5.  Identification of a rat c-erbA alpha-related protein which binds deoxyribonucleic acid but does not bind thyroid hormone.

Authors:  M A Lazar; R A Hodin; D S Darling; W W Chin
Journal:  Mol Endocrinol       Date:  1988-10

6.  The c-erb-A gene encodes a thyroid hormone receptor.

Authors:  C Weinberger; C C Thompson; E S Ong; R Lebo; D J Gruol; R M Evans
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

7.  Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system.

Authors:  C C Thompson; C Weinberger; R Lebo; R M Evans
Journal:  Science       Date:  1987-09-25       Impact factor: 47.728

8.  The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.

Authors:  V Kumar; P Chambon
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

9.  Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor.

Authors:  R J Koenig; R L Warne; G A Brent; J W Harney; P R Larsen; D D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  13 in total

1.  Estrogen and thyroid hormone interaction on regulation of gene expression.

Authors:  Y S Zhu; P M Yen; W W Chin; D W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  The orphan receptor Rev-ErbA alpha activates transcription via a novel response element.

Authors:  H P Harding; M A Lazar
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

3.  Molecular cloning of a novel member of the nuclear receptor superfamily related to the orphan receptor, TR2.

Authors:  S W Law; O M Conneely; B W O'Malley
Journal:  Gene Expr       Date:  1994

4.  The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.

Authors:  H W Chen; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

5.  Thyroid hormone alters the DNA binding properties of chicken thyroid hormone receptors alpha and beta.

Authors:  M L Andersson; K Nordström; S Demczuk; M Harbers; B Vennström
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

6.  Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.

Authors:  R Wong; X G Zhu; M A Pineda; S Y Cheng; B D Weintraub
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

7.  Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.

Authors:  Y Hayashi; T Sunthornthepvarakul; S Refetoff
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

8.  Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.

Authors:  M Adams; C Matthews; T N Collingwood; Y Tone; P Beck-Peccoz; K K Chatterjee
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

9.  An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.

Authors:  M E Geffner; F Su; N S Ross; J M Hershman; C Van Dop; J B Menke; E Hao; R K Stanzak; T Eaton; H H Samuels
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families.

Authors:  R E Weiss; M Weinberg; S Refetoff
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.